Aristolochic acid DCAS# 17413-38-6 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 17413-38-6 | SDF | Download SDF |
| PubChem ID | 161218 | Appearance | Orange-red powder |
| Formula | C17H11NO8 | M.Wt | 357.3 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Synonyms | Aristolochic acid Iva | ||
| Solubility | Soluble in DMSO; sparingly soluble in water | ||
| Chemical Name | 10-hydroxy-8-methoxy-6-nitronaphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid | ||
| SMILES | COC1=CC(=CC2=C3C(=C(C=C12)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O)O | ||
| Standard InChIKey | PADIFGYTAXNCRK-UHFFFAOYSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Chinese-herb nephropathy (CHN) is a rapidly progressive renal fibrosis associated with the intake of a Chinese herb (Aristolochia fangchi) containing nephrotoxic and carcinogenic aristolochic acids . |
Aristolochic acid D Dilution Calculator
Aristolochic acid D Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.7988 mL | 13.9938 mL | 27.9877 mL | 55.9754 mL | 69.9692 mL |
| 5 mM | 0.5598 mL | 2.7988 mL | 5.5975 mL | 11.1951 mL | 13.9938 mL |
| 10 mM | 0.2799 mL | 1.3994 mL | 2.7988 mL | 5.5975 mL | 6.9969 mL |
| 50 mM | 0.056 mL | 0.2799 mL | 0.5598 mL | 1.1195 mL | 1.3994 mL |
| 100 mM | 0.028 mL | 0.1399 mL | 0.2799 mL | 0.5598 mL | 0.6997 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 3-(4-Pyridyl)-D-Alanine.2HCl
Catalog No.:BCC2650
CAS No.:174096-41-4
- Tomatine
Catalog No.:BCN2966
CAS No.:17406-45-0
- Bevirimat
Catalog No.:BCC5312
CAS No.:174022-42-5
- Dehydroabietic acid
Catalog No.:BCN1119
CAS No.:1740-19-8
- Nepicastat
Catalog No.:BCC1795
CAS No.:173997-05-2
- 5-Acetyl-6-hydroxy-2-(1-hydroxy-1-methylethyl)benzofuran
Catalog No.:BCN7495
CAS No.:173992-05-7
- 22-Hydroxy-3-oxo-12-ursen-30-oic acid
Catalog No.:BCN1526
CAS No.:173991-81-6
- Tanshinone IIB
Catalog No.:BCN1118
CAS No.:17397-93-2
- SYM 2206
Catalog No.:BCC6866
CAS No.:173952-44-8
- Isogambogenin
Catalog No.:BCN3066
CAS No.:173938-23-3
- Atrasentan
Catalog No.:BCC1379
CAS No.:173937-91-2
- Gambogenic acid
Catalog No.:BCN3077
CAS No.:173932-75-7
- 3-Chloro-4-hydroxypiperidin-2-one
Catalog No.:BCN3992
CAS No.:174204-83-2
- Methyl 3-(2,4-dihydroxyphenyl)propionate
Catalog No.:BCN1525
CAS No.:17422-90-1
- Pancixanthone A
Catalog No.:BCN7379
CAS No.:174232-30-5
- Apigenin 7-O-(2G-rhamnosyl)gentiobioside
Catalog No.:BCN1524
CAS No.:174284-20-9
- Epimedin K
Catalog No.:BCN8201
CAS No.:174286-13-6
- Caohuoside E
Catalog No.:BCN8198
CAS No.:174286-23-8
- Astragaloside
Catalog No.:BCN5959
CAS No.:17429-69-5
- Picropodophyllotoxin
Catalog No.:BCN2585
CAS No.:17434-18-3
- Tsugaric acid A
Catalog No.:BCN2980
CAS No.:174391-64-1
- Riluzole
Catalog No.:BCC3849
CAS No.:1744-22-5
- Amiloride HCl dihydrate
Catalog No.:BCC5068
CAS No.:17440-83-4
- Sanggenol A
Catalog No.:BCN3602
CAS No.:174423-30-4
6-O-beta-D-glucoside of aristolochic acid IIIa and other components from the roots of Aristolochia baetica.[Pubmed:17252385]
Planta Med. 1997 Dec;63(6):579.
From the root extract of the European Aristolochia baetica L. we isolated aristolochic acid IIIa-6-O-beta-D-glucoside (1) besides magnoflorine chloride, the free aristolochic acids I and II, and five aristolactams. Saccharose and fructose were found as major constituents.
Urinary d-lactate levels reflect renal function in aristolochic acid-induced nephropathy in mice.[Pubmed:23553367]
Biomed Chromatogr. 2013 Sep;27(9):1100-6.
Urinary d-lactate is highly correlated to diabetic nephropathy - a progressive kidney disease in renal glomeruli. In this study, we used a C3H/3e mouse model to investigate the relationship between urinary d-lactate and aristolochic acid nephropathy where the glomerular structure is not affected. The nephropathy was induced using intravenous injections of aristolochic acid at a dosage of 10 mg/kg per day for 5 days and was characterized biochemically and histologically. The urinary excretions of proteins, N-acetyl-beta-d-glucosaminidase and serum creatinine were determined and connected to histological conventional findings. Urinary d-lactate was analyzed using column-switching high-performance liquid chromatography with fluorescence detection. The results showed a remarkable increase of urinary markers, including of urinary proteins and N-acetyl-beta-d-glucosaminidase, and the histological examination confirmed a diagnosis of acute tubule necrosis. The ratio of d-lactate to creatinine in the urine of aristolochic acid-treated mice was approximately 36 times greater than that of the mice in the control group (p < 0.05). The ratios for the two groups of mice were 311.00 +/- 71.70 and 8.60 +/- 1.80 micromol/mmol creatinine, respectively. These data confirm in vivo that urinary d-lactate reflects renal injury conditions in aristolochic acid-treated mice and may be a marker for the assessment of nephropathy.
Aristoxazole analogues. Conversion of 8-nitro-1-naphthoic acid to 2-methylnaphtho[1,2-d]oxazole-9-carboxylic acid: comments on the chemical mechanism of formation of DNA adducts by the aristolochic acids.[Pubmed:22746540]
J Nat Prod. 2012 Jul 27;75(7):1414-8.
2-Methylnaphtho[1,2-d]oxazole-9-carboxylic acid was obtained by reduction of 8-nitro-1-naphthoic acid with zinc-acetic acid. This naphthoxazole is a condensation product between an 8-nitro-1-naphthoic acid reduction intermediate and acetic acid and is a lower homologue of aristoxazole, a similar condensation product of aristolochic acid I with acetic acid that was previously reported. Both oxazoles are believed to arise via a common nitrenium/carbocation ion mechanism that is likely related to that which leads to aristolochic acid-DNA-adducts.
